Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2026-05-27 @ 2:00 AM
Study NCT ID:
NCT07250269
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2025-10-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
Sponsor:
Gracell Biotechnologies (Shanghai) Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed/Refractory AL Amyloidosis | View |
Keywords: